Vera Therapeutics Announces Late-Breaking Oral Presentation
NewsletterReceive the most important news of the day by email
Two informational posters for ORIGIN Phase 3 and ORIGIN Extend trials of
atacicept in IgAN accepted for presentation at Kidney Week...
29 minutes ago
from: GlobeNewswire